Diplomat Pharmacy (DPLO) Tops Q1 EPS by 4c, Offers FY Guidance

Diplomat Pharmacy (NYSE: DPLO) reported Q1 EPS of $0.19, $0.04 better than the analyst estimate of $0.15. Revenue for the quarter came in at $1.08 billion versus the consensus estimate of $1.08 billion.

GUIDANCE:

Diplomat Pharmacy sees FY2017 EPS of $0.54-$0.74, versus the consensus of $0.64. Diplomat Pharmacy sees FY2017 revenue of $4.3-4.7 billion, versus the consensus of $4.53 billion.

For earnings history and earnings-related data on Diplomat Pharmacy (DPLO) click here.

You May Also Be Interested In

• Freightos Limited (CRGO) Tops Q2 EPS by 3c ; Offers Guidance
• Bimergen Energy Corporation (BESS) Reports Q2 EPS of $0.22
• BofA Securities Reiterates Buy Rating on Micron Technology (MU); Sees $230+ in EPS by FY30